Douglas R Den-Otter

Title: Douglas R Den-Otter: Innovator in Neoplastic Disease Treatment

Introduction

Douglas R Den-Otter is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of medical research, particularly in the treatment of neoplastic diseases. His innovative work focuses on the development of inhibitors that target specific biological activities related to cancer.

Latest Patents

Den-Otter holds a patent for "Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3." This patent describes the use of inhibitors that reduce the expression or biological activities of laminin5beta3 in mammalian cells. The inhibitors include antisense molecules, ribozymes, antibodies, and small molecules. These innovations are crucial for developing methods to inhibit the proliferation of tumor cells and treat various neoplastic diseases.

Career Highlights

Den-Otter's career is marked by his work at Chiron Corporation, where he has been instrumental in advancing research related to cancer treatment. His expertise in the field has led to the development of groundbreaking therapies that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Den-Otter has collaborated with esteemed colleagues, including Anne B Jefferson and Jill Winter. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.

Conclusion

Douglas R Den-Otter's contributions to the field of neoplastic disease treatment exemplify the impact of innovation in medical research. His work continues to pave the way for new therapeutic approaches that can significantly benefit patients.